Darunavir pharmacokinetics throughout pregnancy and postpartum

INTRODUCTION: Antiretroviral therapy is recommended during pregnancy for prevention of mother-to-child transmission (MTCT) of HIV. Physiological changes during pregnancy are known to affect the pharmacokinetics (PK) of protease inhibitors (PIs), leading to lower exposures in pregnant women. Here we...

Descripción completa

Detalles Bibliográficos
Autores principales: Lambert, John, Jackson, Valerie, Else, Laura, Lawless, Mairead, McDonald, Grainne, Le Blanc, Dave, Patel, Anjali, Stephens, Kelly, Khoo, Saye
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International AIDS Society 2014
Materias:
Oral Presentation – Abstract O132
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4224853/
https://www.ncbi.nlm.nih.gov/pubmed/25393994
http://dx.doi.org/10.7448/IAS.17.4.19485

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4224853/
https://www.ncbi.nlm.nih.gov/pubmed/25393994
http://dx.doi.org/10.7448/IAS.17.4.19485

Ejemplares similares